Long-awaited findings from the IMMUNEBRIDGE study reveal gaps in SARS-CoV-2 immunity Coronavirus Disease COVID IMMUNEBRIDGE Immunity medrxivpreprint
By Bhavana KunkalikarFeb 22 2023Reviewed by Benedette Cuffari, M.Sc. *Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.
After the summer of 2022, the lack of data suitable for providing evidence of population immunity across Germany was due to the absence of coordinated population panels. In addition, there was considerable uncertainty surrounding the selection of appropriate endpoints related to correlates of protection against severe SARS-CoV-2 infection that would facilitate their usage in real-time decision-making.
The vaccination and illness histories of participating individuals were collected. This information was harmonized across all studies utilizing a collectively developed minimal data set . Immunology eBook Compilation of the top interviews, articles, and news in the last year. Download a free copy Four additional cross-sectional studies were established, including the GUIDE study to assess regional depth and studies from the University Hospitals in Bochum, Dresden, and Wurzburg to provide pertinent data related to pediatric cases.
Across all age categories, the proportion of individuals with fewer than three exposure cases was lower. However, the number of those with no documented exposure was higher, especially among those under the age of 18.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A possible link between aggregation of SARS-CoV-2 proteins and protein misfolding diseasesA possible link between aggregation of SARS-CoV-2 proteins and protein misfolding diseases Protein SARS SARSCoV2 Coronavirus Disease COVID NatureComms iit__mandi Cambridge_Uni CSIR_IMTECH
Read more »
RBD-NTD-subunit protein vaccine provides a promising booster vaccination strategy capable of protecting against known SARS-CoV-2 variantsRBD-NTD-subunit protein vaccine provides a promising booster vaccination strategy capable of protecting against known SARS-CoV-2 variants WellingtonUni otago UniMelb protein vaccine booster vaccination SARSCoV2
Read more »
Factors associated with resistance to SARS-CoV-2 infection discovered using large-scale medical record data and machine learningThere have been over 621 million cases of COVID-19 worldwide with over 6.5 million deaths. Despite the high secondary attack rate of COVID-19 in shared households, some exposed individuals do not contract the virus. In addition, little is known about whether the occurrence of COVID-19 resistance differs among people by health characteristics as stored in the electronic health records (EHR). In this retrospective analysis, we develop a statistical model to predict COVID-19 resistance in 8,536 individuals with prior COVID-19 exposure using demographics, diagnostic codes, outpatient medication orders, and count of Elixhauser comorbidities in EHR data from the COVID-19 Precision Medicine Platform Registry. Cluster analyses identified 5 patterns of diagnostic codes that distinguished resistant from non-resistant patients in our study population. In addition, our models showed modest performance in predicting COVID-19 resistance (best performing model AUROC=0.61). Monte Carlo simulations conducted indicated that the AUROC results are statistically significant (p | 0.001) for the testing set. We hope to validate the features found to be associated with resistance/non-resistance through more advanced association studies.
Read more »
Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolinsResearchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins CellPressNews coronavirus virus virology zoonoticdisease infectiousdisease
Read more »
Coding long COVID: characterizing a new disease through an ICD-10 lens - BMC MedicineBackground Naming a newly discovered disease is a difficult process; in the context of the COVID-19 pandemic and the existence of post-acute sequelae of SARS-CoV-2 infection (PASC), which includes long COVID, it has proven especially challenging. Disease definitions and assignment of a diagnosis code are often asynchronous and iterative. The clinical definition and our understanding of the underlying mechanisms of long COVID are still in flux, and the deployment of an ICD-10-CM code for long COVID in the USA took nearly 2 years after patients had begun to describe their condition. Here, we leverage the largest publicly available HIPAA-limited dataset about patients with COVID-19 in the US to examine the heterogeneity of adoption and use of U09.9, the ICD-10-CM code for “Post COVID-19 condition, unspecified.” Methods We undertook a number of analyses to characterize the N3C population with a U09.9 diagnosis code (n = 33,782), including assessing person-level demographics and a number of area-level social determinants of health; diagnoses commonly co-occurring with U09.9, clustered using the Louvain algorithm; and quantifying medications and procedures recorded within 60 days of U09.9 diagnosis. We stratified all analyses by age group in order to discern differing patterns of care across the lifespan. Results We established the diagnoses most commonly co-occurring with U09.9 and algorithmically clustered them into four major categories: cardiopulmonary, neurological, gastrointestinal, and comorbid conditions. Importantly, we discovered that the population of patients diagnosed with U09.9 is demographically skewed toward female, White, non-Hispanic individuals, as well as individuals living in areas with low poverty and low unemployment. Our results also include a characterization of common procedures and medications associated with U09.9-coded patients. Conclusions This work offers insight into potential subtypes and current practice patterns around long COVID and spe
Read more »
Nicola Bulley: Why can it take so long to find bodies?The science, skills and practice of finding bodies in water shows it is one of the toughest challenges in policing.
Read more »